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ABSTRACT
Nonalcoholic fatty liver disease (NAFLD) is caused by ectopic fat accumulation 
in the liver. NAFLD is associated with hepatic inflammation and oxidative stress, 
resulting in nonalcoholic steatohepatitis (NASH) with advanced fibrosis. Placental 
extracts have been used to treat various chronic diseases due to their antioxidative 
effect. However, the effects of the extracts on the development of NASH have yet 
to be elucidated. Here, we demonstrated that supplementation with an oral porcine 
placental extract (PPE) attenuated lipid accumulation and peroxidation, insulin 
resistance, inflammatory and stress signaling, and fibrogenesis in the liver of NASH 
model mice fed a high-cholesterol and high-fat diet. The PPE reduced the number of 
M1-like liver macrophages, but increased the number of anti-inflammatory M2-like 
macrophages, resulting in a predominance of M2 over M1 macrophage populations in 
the liver of NASH mice. Accordingly, the PPE suppressed lipopolysaccharide-induced 
M1 polarization in isolated murine peritoneal macrophages, whereas it facilitated 
interleukin 4-induced M2 polarization. Furthermore, the PPE reduced the hepatic 
stellate cell (HSC) activation associated with the attenuated transforming growth 
factor-β/Smad3 signaling, both in the liver of NASH mice and in RI-T cells, a HSC line. 
The PPE may be a potential approach to prevent NASH by limiting lipid peroxidation, 
promoting M2 macrophage polarization, and attenuating HSC activation.
INTRODUCTION
Nonalcoholic fatty liver disease (NAFLD) is 
frequently described as a spectrum of diseases from simple 
steatosis to nonalcoholic steatohepatitis (NASH) with 
advanced fibrosis [1]. A “multiple-parallel-hit” theory has 
been proposed in which dysregulated lipid metabolism and 
insulin resistance are the “first-hit” to the liver, followed 
by a “second-hit”, or “multi-hits”, such as oxidative 
stress and pro-inflammatory chemokines and cytokines 
[2, 3]. Along with the development of NASH, oxidative 
stress and pro-inflammatory cytokines activate immune 
cells, such as liver macrophages (i.e., Kupffer cells) and 
T-lymphocytes. Activation of these immune cells results 
in chronic inflammation and insulin resistance in the liver 
[4–8]. Our previous study developed a cholesterol- and 
saturated fatty acid-induced mouse model of lipotoxic 
NASH, replicating the pathophysiological features 
of human NASH [8, 9]. The liver of this model mouse 
exhibits excessive lipid accumulation and aberrant 
activation of liver macrophages and hepatic stellate cells 
(HSCs), resulting in the exacerbation of hepatic insulin 
resistance, inflammation, and fibrosis [9]. 
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To date several pharmacological agents, such as 
metformin [10], thiazolidinediones [11], vitamin E [12], 
and carotenoids [13, 14] have been tested as treatments for 
NASH. However, these agents are generally insufficient 
to ameliorate liver inflammation and fibrosis, and have 
raised safety concerns. Therefore, a potential therapy 
with minimal adverse effects has been eagerly awaited. 
Placental extracts prepared from human or animal placenta 
have been used as ingredients in medicines, health foods, 
and cosmetics. Orally administered placental extracts have 
been reported to be effective for menopausal disorders 
[15, 16] and their symptoms (e.g., knee pain, shoulder 
stiffness, and wrinkles below the eyes) [17–19]. Togashi 
et al. reported that an orally administered human placental 
extract inhibits alcohol-induced hepatic disorder in a 
mouse model [20, 21]. Moreover, recent clinical studies 
have reported that a human placental extract decreases 
plasma levels of alanine aminotransferase (ALT) and 
aspartate aminotransferase (AST) and prevents the 
progression of alcoholic hepatitis and NASH in human 
patients [22, 23]. However, the underlying mechanisms of 
action of placental extracts have not been fully elucidated.
Porcine placental extract (PPE) have been developed 
as an alternative source to human placental extracts due 
to biosafety concerns [17–19, 24]. In the current study, 
we examined PPE-mediated mitigation of oxidative 
stress, insulin resistance, lipid accumulation, chronic 
inflammation, and fibrosis in the liver of a diet-induced 
NASH mouse model.
RESULTS
The PPE alleviates hepatic steatosis and 
oxidative stress in NASH mice 
A high-fat, high-cholesterol, and cholate (CL) diet 
induces hepatic steatosis and inflammation, eventually 
leading to steatohepatitis in C57BL/6J mice similar to 
that of human NASH [8, 9]. To determine the effect of 
the PPE on diet-induced NASH, we fed C57BL/6J mice 
with normal chow (NC), the CL diet, or the CL diet 
supplemented with 0.1% (w/w) or 0.3% (w/w) PPE for 
15 weeks. The CL diet significantly increased liver weight 
(Figure 1B) and plasma AST and ALT levels (Figure 1C). 
PPE supplementation attenuated the increase in liver weight 
caused by the CL diet (Figure 1B), without reducing body 
weight (Figure 1A) or food intake (Table 1). Additionally, 
the PPE decreased plasma AST and ALT levels dose-
dependently, suggesting alleviation of CL diet-induced liver 
damage (Figure 1C). In parallel, the PPE significantly 
attenuated hepatic steatosis (Figure 1D), and the increase 
in liver triglyceride (TG) and non-esterified fatty acid 
(NEFA) levels caused by the CL diet (Figure 1E), although 
plasma TG, total cholesterol (TC), and NEFA levels were 
not decreased (Table 1). The reduction in hepatic steatosis 
was accompanied by decreased expression of the lipogenic 
genes sterol regulatory element binding transcription 
factor 1c (Srebf1c) and stearoyl-CoA desaturase 1 (Scd1) 
(Figure 1F). Moreover, the PPE restored the decreased 
expression of genes involved in mitochondrial fatty acid 
β-oxidation (Pparα and Cpt1α) in the liver of CL-diet fed 
mice (Figure 1F). 
The PPE decreases lipid accumulation in 
primary hepatocytes
To examine whether the PPE directly attenuates 
lipid accumulation in hepatocytes, we incubated primary 
hepatocytes with oleate in the presence or absence of the 
PPE. The PPE treatment decreased lipid accumulation, 
as assessed by Oil red O staining, in oleate-loaded 
hepatocytes (Supplementary Figure 1A). The reduction 
in lipid accumulation was accompanied by suppression 
of lipogenic gene (Srebf1c and Fas) expression, and 
by increased expression of genes involved in fatty 
acid oxidation (Pparα, Cpt1α, Lcad, and Acox1) and 
lipid transport (Lcat, Apob, and Mttp) in oleate-treated 
hepatocytes (Supplementary Figure 1B). Furthermore, 
to evaluate the effect of the PPE on oxidative stress 
in CL diet-fed mice, we determined the hepatic and 
plasma levels of thiobarbituric acid reactive substances 
(TBARS), a marker of lipid peroxidation. The PPE 
decreased lipid peroxidation (Table 1 and Figure 1G) and 
decreased hepatic gene expression of the NADPH oxidase 
subunits (Figure 1H), whereas it increased expression 
of antioxidative stress genes in the liver of NASH mice 
(Figure 1I).
The PPE restores glucose intolerance and insulin 
sensitivity in NASH mice
Ectopic fat accumulation in the liver has been linked 
to the development of glucose intolerance and insulin 
resistance [1]. We performed the glucose tolerance test 
(GTT) to determine whether the PPE improves glucose 
metabolism in NASH mice. PPE supplementation 
improved glucose tolerance in CL diet-fed mice during 
the GTT (Figure 2A), although insulin secretion during 
the GTT was not decreased by the PPE (data not shown). 
We also performed biochemical studies to investigate the 
effect of the PPE on insulin sensitivity, and found that 
PPE administration restored insulin-stimulated tyrosine 
phosphorylation of insulin receptor β subunit (p-IRβ) and 
serine phosphorylation of Akt (p-Akt) in the liver and 
skeletal muscle of CL diet-fed mice (Figure 2B and 2C).
The PPE attenuates inflammation and 
endoplasmic reticulum (ER) stress in the liver of 
NASH mice
Chemokine (C-C motif) ligand 2 (Ccl2) increases 
recruitment of Ccl2 receptor (Ccr2)-positive inflammatory 
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monocytes into the liver [25, 26]. These recruited cells 
produce large amounts of proinflammatory mediators and 
promote insulin resistance and NASH in mice [27]. Here, 
we found marked induction of Ccl2, Ccr2, and interleukin 
(IL)-1β in the liver of CL diet-fed mice, which decreased 
significantly in PPE-treated mice (Figure 3A). The PPE 
also tended to decrease mRNA expression of tumor 
necrosis factor (Tnf)-α (Figure 3A). Additionally, the PPE 
significantly suppressed CL diet-induced phosphorylation 
of c-Jun N-terminal kinase (JNK) and extracellular signal-
regulated kinase (ERK), and tended to decrease levels of 
phosphorylated nuclear kappa beta (p-NF-κB) p65 in the 
CL + 0.3% PPE group, although this decrease was not 
significant (Figure 3B and 3C). Moreover, the PPE also 
decreased the protein levels of phosphorylated eIF2α, 
GRP78, and CHOP, which are involved in ER stress 
(Figure 3B and 3C). In accordance with attenuated hepatic 
inflammation, the plasma levels of IL-6 and CCL2 also 
decreased in response to PPE supplementation (Table 1). 
The PPE causes a predominance of M2 over M1 
macrophage populations in the liver of NASH 
mice
Significant improvements in chronic inflammation 
in the liver of PPE-treated NASH mice prompted us to 
investigate the effects of the PPE on the homeostasis 
of hepatic macrophages. Here, we found that the PPE 
tended to decrease the number of F4/80+-cells in the liver 
of NASH mice, as assessed by immunostaining (Figure 
4A) and mRNA expression levels of the macrophage 
marker F4/80 (Figure 4B). To quantify the numbers of 
total (CD45+CD11b+F4/80+), pro-inflammatory M1-
like (CD11c+CD206-), and anti-inflammatory M2-like 
(CD11c-CD206+) macrophages in the liver, we analyzed 
hepatic immune cells by fluorescence-activated cell 
sorting (FACS). Compared with the NC group, the 
number of total macrophages and M1-like macrophages 
in the liver increased by 1.6-fold and 3.8-fold in the CL 
group, respectively, suggesting that the CL diet induced 
accumulation of pro-inflammatory macrophages (Figure 
4C–4E). Although the PPE did not alter the total number 
of liver macrophages markedly, it decreased M1-like 
macrophage accumulation by 44.2% compared with that 
in the CL group (Figure 4D and 4E). In contrast, the PPE 
increased the number of M2-like liver macrophages by 
1.4-fold, resulting in a predominant M2-like macrophage 
population (Figure 4D and 4E). In accordance with these 
findings, mRNA expression of the M1-like macrophage 
marker gene, Cd11c, decreased in response to the 
PPE (Figure 4F), whereas gene expression of M2-like 
macrophage markers, including Arg1, Cd206, Il-10, and 
Cd163 increased in response to the PPE (Figure 4F). 
These results suggest that the PPE caused a shift to an 
M2-dominant macrophage phenotype, which contributed 
to the attenuation of CL diet-induced inflammation.
The PPE directly regulates M1/M2 polarization 
in peritoneal macrophages and inflammatory 
signaling in primary hepatocytes
To test whether the PPE suppresses M1 polarization, 
but facilitates M2 polarization in vitro, we treated 
isolated peritoneal macrophages from C57BL/B6 mice 
with the PPE. PPE decreased the expression of CD11c, 
inflammatory cytokines (Tnf-α and Il-1β), and chemokine 
(Ccl2) in lipopolysaccharide (LPS)-stimulated macrophages 
(Figure 5A). In contrast, the PPE enhanced expression of 
the M2 marker genes (Arg1, Cd206, Chi3l3, and IL-10) in 
IL 4-stimulated macrophages (Figure 5B). LPS-mediated 
reactive oxygen species (ROS) production causes M1 
polarization and suppresses M2 polarization in macrophages 
through activation of the mitogen-activated protein kinase 
(MAPK) and NF-κB pathways [28–30]. We determined 
that the increase in ROS generation in macrophages was 
diminished in the presence of the PPE (Figure 5C). These 
findings were associated with decreased mRNA expression 
of the NADPH oxidase subunits and increased mRNA 
expression of antioxidative stress genes in LPS-stimulated 
macrophages (Figure 5D). Moreover, the PPE significantly 
Table 1: Metabolic parameters after 15 weeks of feeding
NC CL CL + 0.1% PPE CL + 0.3% PPE
Food intake (Kcal/day) 12.3 ± 0.3 11.1 ± 0.4* 13.0 ± 0.3# 12.9 ± 0.5##
Plasma TG (mg/dL) 36.7 ± 3.8 14.9 ± 2.2* 12.8 ± 4.0 12.8 ± 3.0
Plasma TC (mg/dL) 65.2 ± 4.2 97.7 ± 3.0** 97.3 ± 11.6 101.7 ± 9.9
Plasma NEFA (mmol/L) 1.7 ± 0.1 0.9 ± 0.1** 0.8 ± 0.1 0.7 ± 0.1
Plasma TBARS (nmol/mL) 1.6 ± 0.9 2.2 ± 0.2** 2.0 ± 0.2 1.4 ± 0.1#
Plasma IL-6 (pg/mL) 1.4 ± 0.3 8.9 ± 0.8** 4.9 ± 0.3# 5.2 ± 1.2#
Plasma CCL-2 (pg/mL) 8.7 ± 1.1 25.7 ± 4.1** 18.9 ± 3.4 14.4 ± 1.8#
Food intake was determined at the middle period of PPE treatment. Plasma parameters data were obtained from 23-week-old 
mice on different diets. For measuring the plasma metabolic parameters, the fasting blood was collected from the mice fasted 
for 16 hours. Data are presented as means ± SEM (n = 6–8). *P < 0.05, **P < 0.01 vs. NC diet-fed mice. #P < 0.05, ##P < 0.01, 
vs. CL diet-fed mice.
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Figure 1: Porcine placental extract (PPE) supplementation attenuates hepatic steatosis in CL diet-fed mice. (A) Body 
weights of the mice. (B) Liver weights of the mice. (C) Levels of plasma aspartate aminotransferase (AST) and alanine aminotransferase 
(ALT). (D) Representative hematoxylin and eosin-stained liver section. Scale bars = 100 μm. (E) Levels of hepatic triglycerides (TG), total 
cholesterol (TC), and non-esterified fatty acids (NEFA). (F) Quantitative real-time PCR of hepatic mRNA expression of genes involved in 
fatty acid synthesis and β-oxidation. (G) Levels of hepatic thiobarbituric acid reactive substances (TBARS). (H) Hepatic mRNA expression 
of NADPH oxidase complex. (I) Hepatic mRNA expression of antioxidant genes. n = 6–8. *P < 0.05, **P < 0.01 vs. normal chow (NC) 
diet-fed mice. #P < 0.05, ##P < 0.01, vs. CL diet-fed mice.
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suppressed LPS-induced phosphorylation of MAPK (p38 
and Erk) and NF-κB p65 in mice RAW264.7 macrophages 
(Figure 5E). The PPE also decreased expression of Tnf-α, 
Il-1β, Ccl2, and Ccl5 in LPS- or palmitate-stimulated 
primary hepatocytes (Supplementary Figure 2A and 2B). 
Additionally, the PPE significantly suppressed palmitate-
induced phosphorylation of p38 MAPK and ERK 
(Supplementary Figure 2C). These findings in peritoneal 
macrophages and primary hepatocytes indicate that the PPE 
may alleviate inflammatory signaling through a direct cell-
autonomous mechanism.
The PPE attenuates hepatic fibrosis in NASH 
mice and suppresses TGFβ signaling in a rat 
stellate cell line
Next, we determined the effects of the PPE on hepatic 
fibrosis in NASH mice. Histological analyses with Sirius 
Red and Azan staining revealed that hepatic fibrosis was 
induced by the CL diet, and attenuated by supplementation 
with 0.3% PPE (Figure 6A). Consistent with the histological 
findings, the PPE reduced hepatic hydroxyproline, a marker 
of collagen fiber content (Figure 6B). Moreover, the number 
of α-smooth muscle actin (SMA)-positive activated HSCs, 
a major fibrogenic cell, increased in response to the CL 
diet, and decreased in response to the PPE (Figure 6A). 
The decrease in number of α-SMA+ cells caused by the 
PPE was further verified by the results of quantitative real-
time polymerase chain reaction (PCR) (Figure 6C) and 
immunoblotting (Figure 6D). Additionally, compared with 
the NC diet, the CL diet increased mRNA expression of 
fibrogenic genes, including Tgfβ1, collagen type I, alpha 1 
(Col1α1), and plasminogen activator inhibitor-1 (Serpine-1) 
(Figure 6C). In contrast, PPE administration decreased the 
expression of these fibrogenic genes (Figure 6C). Smad3 
is a key transcription factor required for TGFβ-induced 
Figure 2: PPE supplementation ameliorates glucose intolerance and insulin sensitivity in CL diet-fed mice. (A) Glucose 
tolerance test (GTT; 2 g/kg body weight) after 14 weeks (n = 6–8/group). Area under the curve calculations. (B, C). Mice on the indicated 
diet for 15 weeks were injected in the tail vein with saline (n = 3/group) or insulin (n = 4/group, 5 U/kg body weight), and killed 7 min after 
the injection. Total liver and quadriceps muscle lysates were immunoblotted for p-IRβ, IRβ, p-Akt, and Akt, quantitated, and presented as 
means ± SEM. *P < 0.05, **P < 0.01 vs. NC diet-fed mice. #P < 0.05, ##P < 0.01, vs. CL diet-fed mice.
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Figure 3: PPE attenuates hepatic inflammation in nonalcoholic steatohepatitis (NASH) mice. (A) mRNA expression of 
chemokine (C-C motif) ligand 2 (Ccl2), Ccl2 receptor (Ccr2), interleukin (Il)-1β, and tumor necrosis factor (Tnf)-α in the liver. (B). 
Immunoblot of p-Jun N-terminal kinase (p-JNK), p-extracellular signal-regulated kinase (p-ERK), phosphorylated nuclear kappa beta 
(p-NF-κB), p-eIF2α, GRP78, and CHOP in the liver. (C) Quantification of p-JNK, p-ERK, p-NF-κB, p-eIF2α, GRP78, and CHOP in the 
liver. n = 6–8. *P < 0.05, **P < 0.01 vs. NC diet-fed mice. #P < 0.05, ##P < 0.01, vs. CL diet-fed mice.
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Figure 4: PPE promotes a predominance of M2 macrophage populations over M1 in the liver. (A) Representative F4/80-
stained liver section. Scale bars = 100 μm. (B) mRNA expression of F4/80 in the liver. (C) Representative plot of total macrophages in 
the liver. (D) Frequency of M1, M2-type macrophages in the liver. (E) Quantitation of total macrophages, percentages of M1, M2-type 
macrophages and the M1/M2 macrophage ratios in the liver. (F) mRNA expression of Cd11c and M2 markers in the liver. *P < 0.05, **P < 
0.01 vs. NC diet-fed mice. #P < 0.05, ##P <  0.01, vs. CL diet-fed mice.
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extracellular matrix synthesis-activated HSCs [31–33]. The 
PPE tended to decrease CL diet-induced phosphorylation of 
Smad3, and significantly decreased α-SMA protein levels in 
the liver (Figure 6D). To examine whether the PPE directly 
suppressed activation of stellate cells, we assessed the effect 
of the PPE on TGFβ signaling in the RI-T rat stellate cell 
line. The PPE decreased TGFβ-induced phosphorylation of 
Smad3 and α-SMA protein levels in RI-T cells (Figure 6E). 
Consistently, the PPE reduced mRNA expression of TGFβ-
induced fibrogenic genes (Col1a1 and fibronectin) (Figure 
6F). Moreover, the PPE decreased mRNA expression of 
Nox4 and intracellular ROS levels in TGFβ-stimulated RI-T 
cells (Figure 6G).
DISCUSSION
In the current study, we demonstrated that the 
PPE mitigated hepatic steatosis, oxidative stress, insulin 
resistance, hepatic inflammation, and fibrosis in diet-
induced NASH mice. In addition, our in vitro studies 
Figure 5: PPE directly inhibits activation of M1 macrophages and enhances M2 macrophage activation in vitro. (A) 
mRNA expression of lipopolysaccharide (LPS)-induced M1 markers in peritoneal macrophages. (B) mRNA expression of IL-4-induced 
M2 markers in peritoneal macrophages. (C) Reactive oxygen species (ROS) production in LPS-treated peritoneal macrophages. (D) mRNA 
expression of NADPH oxidase subunit and anti-oxidative stress-related genes in LPS-treated peritoneal macrophages. (E) Immunoblot of 
p-p38MAPK, p-ERK, and p-NF-κB in LPS-treated Raw264.7 macrophages. n = 6. *P < 0.05, **P < 0.01, vs. no treatment cells. #P < 0.05, 
##P < 0.01, vs. LPS- and IL4-treated cells. 
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Figure 6: PPE attenuates hepatic fibrosis in NASH mice. (A) Representative Azan, Sirius Red, and α-SMA immunostained 
liver sections. Scale bars = 100 μm. (B) Hydroxyproline contents in the liver. (C) mRNA expression of fibrogenic genes in the liver. (D) 
Immunoblot and quantification of p-Smad3 and α-SMA in the liver. n = 6–8. *P < 0.05, **P < 0.01 vs. NC diet-fed mice. #P < 0.05, ##P < 
0.01, vs. CL diet-fed mice. (E) Immunoblot and quantification of p-Smad3 and α-SMA in TGFβ-treated RI-T cells. (F) mRNA expression 
of fibrogenic genes in TGFβ1-treated RI-T cells. (G) mRNA expression of Nox4 and ROS production in TGFβ-treated RI-T cells. n = 6. *P 
< 0.05, **P < 0.01, vs. no treatment cells. #P < 0.05, ##P < 0.01, vs. TGFβ-treated cells.
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suggest that the PPE may mitigate NASH by acting on 
both parenchymal and non-parenchymal cells of the liver. 
First, the PPE treatment decreased lipid accumulation, 
accompanied by decreased expression of lipogenic genes 
and increased expression of fatty acid oxidation genes 
in oleate-loaded primary hepatocytes. Second, the PPE 
suppressed M1-associated inflammatory signaling, gene 
expression, and ROS production in LPS-stimulated 
peritoneal macrophages. Lastly, the PPE decreased 
TGFβ-induced phosphorylation of Smad3 and α-SMA 
protein levels, as well as intracellular ROS levels in 
RI-T rat stellate cells. These results suggest that the PPE 
mitigates lipid accumulation in hepatocytes and suppresses 
inflammatory activation of hepatic macrophages and 
stellate cells, thereby preventing the progression of NASH.
Our results indicate that the beneficial effects of the 
PPE on hepatic steatosis and insulin sensitivity were not 
secondary to the reduction in body mass and food intake. 
Instead, the PPE mitigated CL diet-induced oxidative 
stress and inflammation in the liver. Hepatic inflammation 
mediated by M1-like liver macrophage-derived ROS, 
cytokines, and chemokines in NASH promotes lipogenesis 
by inhibiting insulin signaling and activation of SREBP 
[25, 34, 35]. In contrast, M2-like macrophages, which 
arise from stimulation by T helper type 2 (Th2) cytokines 
(IL4/13), secrete various anti-inflammatory molecules 
(IL10) [36]. Accumulating evidence has established that 
the development of NASH is strongly influenced by an 
imbalance in the ratio between M1 and M2 macrophages, 
leading to insulin resistance and  chronic inflammation 
[37]. In fact, specific ablation of M1-like macrophages 
restores insulin sensitivity and liver lipid levels in diet-
induced obese mice [38], while deleting Pparδ, which 
promotes M2 polarization, thereby predisposing lean 
mice to develop insulin resistance [39]. Therefore, M2-
dominant polarization of hepatic macrophages accounts, 
at least in part, for the protection against insulin resistance, 
hepatic steatosis, and inflammation in PPE-supplemented 
NASH model mice. 
M1-polarized liver macrophages dominantly 
produce TGFβ1, a key fibrogenic cytokine, which 
facilitates transdifferentiation of quiescent HSCs into 
highly proliferative myofibroblast-like activated HSCs, 
which are pivotal effectors in hepatic fibrogenesis 
[40]. In addition, TGFβ induces NOX4 following ROS 
production during HSC activation, which is required to 
activate hepatic myofibroblasts and express Smad3 [41–
43]. We showed that PPE supplementation suppressed 
activation of HSCs, and decreased expression of 
TGFβ1 in the liver of NASH mice. Additionally, PPE 
suppressed TGFβ signaling and decreased intracellular 
ROS levels, accompanied by decreased expression 
of NOX4 in RI-T cells. Taken together, the PPE may 
alleviate lipotoxicity-induced hepatic fibrosis by 
suppressing TGFβ-mediated activation of HSCs, in 
addition to reducing inflammation.
It remains unclear as to which small molecule(s) in the 
PPE ameliorate diet-induced NASH. The PPE worked as an 
antioxidant in vitro and in vivo, and inhibited and activated 
the expression of genes encoding oxidation-promoting 
and anti-oxidative molecules, respectively. It has been 
reported that some small molecules, such as uracil, tyrosine, 
phenylalanine, and tryptophan, might act as antioxidants in 
the liver when placental extracts are administered orally or 
intramuscularly to rodents [20, 21, 44]. Moreover, the PPE 
is reported to induce genes encoding antioxidative enzymes 
(SOD and catalase) in the B16 mice melanoma cell line 
[45], although the molecules responsible have not been 
identified. However, vitamin C and vitamin E isolated from 
human placenta extracts, show protective effect of cutaneous 
oxidative stress [46]. In addition, trans-4-L-hydroxyprolyl-
L-serine and cyclo-trans-4-L-hydroxyprolyl-L-serine, small 
peptides isolated from a human placental extract, exhibit 
potent antihepatitis activity in a-naphthylisothiocyanate-
intoxicated rats after their oral administration [47]. Taken 
together, we speculate that multiple molecules, both known 
and unknown, together give rise to the anti-NASH effect 
of the PPE in vivo. Future studies are warranted to fully 
determine the molecules that are responsible in the PPE. 
In conclusion, our findings show beneficial effects 
of a placental extract in preventing a spectrum of NASH-
induced hepatic abnormalities, by suppressing excessive 
lipid accumulation and fatty acid peroxidation. The beneficial 
effects of the PPE are, at least in part, due to the M2-dominant 
shift in liver macrophages, and to inhibited HSC activation. 
Thus, the PPE has the potential to prevent the development 
of NASH.
MATERIALS AND METHODS
Porcine placental extract 
The PPE used in this study was produced by 
Snowden Co. Ltd. (Tokyo, Japan) by combining 
fermentation and proteolysis. In brief, porcine placenta 
was obtained as afterbirth and was fermented with 
yeast (Zygosaccharomyces sp.) and lactic acid bacteria 
(Pediococcus sp.) for 1 day. After the supernatant 
was collected, the residual material was subjected to 
proteolysis to obtain the hydrolyzed supernatant. The 
supernatants were combined and lyophilized to afford 
the PPE powder. We chose this type of PPE for this 
study based on preliminary results showing that it was 
more effective than that produced solely by proteolysis 
in inhibiting LPS-induced expression of mRNAs 
encoding inflammatory cytokines (TNFα and IL-1β) in 
mouse peritoneal macrophages (data not shown).
Mice and diets
Eight-week-old male C57BL/6J mice (Charles 
River Laboratories, Yokohama, Japan) were divided 
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into four groups and fed for 15 weeks as follows: 
(1) Normal chow with 10% of calories from fat (NC, 
CRF-1; Charles River); (2) high-fat, high-cholesterol, 
and cholate diet (CL; 60% of calories from fat, 1.25% 
cholesterol, 0.5% sodium cholate; Research Diets, 
Cincinnati, OH, USA); (3) CL diet with 0.1% PPE (CL + 
0.1% PPE); and (4) CL diet with 0.3% PPE (CL + 0.3% 
PPE). All mice were maintained on a 12 h/12-h light/
dark cycle and given free access to food and water. All 
animal procedures were performed in accordance with 
the standards set forth in the Guidelines for the Care 
and Use of Laboratory Animals of Kanazawa University, 
Japan.
Cell lines
RAW264.7 (TIB-71; ATCC, Manassas, VA, USA) 
cells, a murine monocytic cell line, were cultured 
in Dulbecco’s modified Eagle’s medium (DMEM; 
Invitrogen, Carlsbad, CA, USA) supplemented with 10% 
fetal bovine serum (FBS; Invitrogen) in a humidified 
atmosphere of 5% CO2 at 37°C until the cells reached 
90% confluence. The cells were then serum-starved for 6 
hours and incubated with 1 μg/mL LPS (Sigma-Aldrich, 
St. Louis, MO, USA) in the presence of 0, 1, 10, or 100 
µg/mL PPE for 16 h. The LPS-induced inflammatory 
signals were examined by western blotting. 
To investigate the protective effect of the PPE on 
fibrogenesis in vitro, RI-T cells (JCRB1088; JCRB Cell 
Bank, Osaka, Japan) were grown in RPMI1640 medium 
(Invitrogen) supplemented with 10% FBS (Invitrogen) 
in a humidified atmosphere of 5% CO2 at 37°C until the 
cells reached 90% confluence. After serum-starving the 
cells for 6 h, they  were incubated with 3 ng/mL TGFβ 
(R&D Systems, Minneapolis, MN, USA) in the presence 
of 0, 1, 10, or 100 µg/mL PPE for 16 h. 
Biochemical analyses
Plasma TG, TC, NEFA, ALT, AST, insulin, IL-6, 
and CCL2 levels, as well as the hepatic content of TG, 
TC, NEFA, and TBARS, were measured as described 
previously [13, 48]. All hepatic lipids levels were 
normalized to liver protein levels. 
Glucose tolerance test and insulin signaling in 
vivo
Overnight-fasted mice were intraperitoneally 
injected with 2 g/kg body weight D-glucose for the 
GTT, and blood glucose was measured before, and 30, 
60, 90, and 120 min after the injection. Anesthetized 
mice were injected in the tail vein with 5 U/kg body 
weight human insulin (Eli Lilly, Kobe, Japan) for 7 min 
to detect insulin signaling in vivo. Then, the mice were 
killed and the tissues harvested.
Histological examination and 
immunohistochemistry 
Paraffin wax-embedded liver sections were stained 
with hematoxylin and eosin, Sirius Red, Azan and 
immunohistochemically for F4/80 or α-SMA, as described 
previously [13, 49]. 
Hydroxyproline assay 
To assess liver collagen content, hepatic 
hydroxyproline content was measured by a 
spectrophotometric assay, as described previously [50]. 
Briefly, liver tissue was homogenized in ice-cold saline 
(1 mL), and the homogenates were further incubated on 
ice for 30 min with 125 mL of 50% trichloroacetic acid. 
Subsequently, the precipitated pellets were hydrolyzed 
for 24 h at 110°C in 6 N HCl, filtered, and neutralized 
with 10 N NaOH. The hydrolysates were oxidized with 
chloramine-T (Sigma-Aldrich) for 25 min. The reaction 
mixture was incubated in Ehrlich’s perchloric acid 
solution at 65°C for 20 min. Absorbance values were 
measured at 560 nm after cooling the samples to room 
temperature. Hydroxyproline content was normalized to 
the liver protein level.
Quantitative real-time PCR
Quantitative real-time PCR was performed on 
a CFX384 (Bio-Rad, Hercules, CA, USA) using the 
SYBR Green Master Mix (Takara, Shiga, Japan), as 
described previously [49]. Primers used in the real-time 
PCR are shown in Supplementary Table 1. 
Immunoblots
Tissues were homogenized and sonicated in 
RIPA lysis buffer (Millipore, Billerica, MA, USA), 
supplemented with protease and phosphatase inhibitors 
(Roche Diagnostics, Indianapolis, IN, USA). Proteins 
were resolved by sodium dodecyl sulfate-polyacrylamide 
gel electrophoresis and transferred to polyvinylidene fluoride 
membranes. An immunoblot of the lysates was performed 
with primary antibodies (Supplemental Table 2), followed 
by appropriate secondary antibodies, and the proteins were 
visualized using chemiluminescence (Bio-Rad). Pixel 
intensities of the immunoreactive bands were quantified 
using ImageQuant TL (GE Healthcare Life Sciences, 
Tokyo, Japan).
Fluorescence-activated cell sorting analysis 
Isolation and preparation of liver cells were 
described previously [49, 51]. The isolated cells were 
incubated with Fc-Block (BD Bioscience, San Jose, 
CA, USA), followed by incubation with fluorochrome-
Oncotarget15058www.oncotarget.com
conjugated antibodies (Supplementary Table 3). Flow 
cytometry was performed using a FACSAria II (BD 
Bioscience), and data were analyzed using the FlowJo 
software (Tree Star, Ashland, OR, USA).
Isolation of peritoneal macrophages and primary 
hepatocytes and treatment 
Mouse peritoneal macrophages and primary 
hepatocytes were isolated from a male C57BL/6J mouse 
(8–12 weeks old), as described previously [51, 52]. After 
culturing in DMEM (Invitrogen) without FBS for 6 h, 
primary hepatocytes were treated with 400 µM oleate 
(Sigma-Aldrich) and the PPE (0, 1, 10, or 100 µg/mL) 
for 16 h. Oil red O staining was performed on primary 
hepatocytes to evaluate lipid content in the hepatocytes, 
as described previously [13]. Cellular TG levels were 
measured as described previously [48]. 
To determine the effects of the PPE on LPS- or IL-
4-stimulated cells, primary hepatocytes and peritoneal 
macrophages were incubated with 1 μg/mL LPS (Sigma-
Aldrich) or 10 ng/mL IL-4 (Sigma-Aldrich) in the presence 
of 0, 1, 10, or 100 µg/mL of the PPE for 16 h. The mRNA 
levels of M1 and M2 markers in primary hepatocytes and 
peritoneal macrophages were measured by RT-qPCR. 
Finally, to examine the direct effect of the PPE 
on antioxidative stress, intracellular ROS formation 
was determined by the 5-(and-6)-chloromethyl-2’, 7’- 
dichlorodihydrofluorescein diacetateacetylester (CM-
H2DCFDA; Invitrogen) fluorescent probe in peritoneal 
macrophages and RI-T cells, as described previously [51].
Statistics
All data are presented as means ± standard error. 
Differences in mean values between two groups were 
assessed using a two-tailed Student’s t-test. Differences 
in mean values among more than two groups were 
determined by analysis of variance (ANOVA). If the 
one-way ANOVA was significant, differences between 
individual groups were estimated by the Bonferroni post-
hoc test. All calculations were performed with SPSS 
software (ver. 22.0; IBM Corp., Armonk, NY, USA). 
P-values < 0.05 were considered significant. 
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